H.R.2851 - SITSA Act115th Congress (2017-2018) |
|Sponsor:||Rep. Katko, John [R-NY-24] (Introduced 06/08/2017)|
|Committees:||House - Energy and Commerce; Judiciary | Senate - Judiciary|
|Committee Reports:||H. Rept. 115-713|
|Latest Action:||Senate - 06/18/2018 Received in the Senate and Read twice and referred to the Committee on the Judiciary. (All Actions)|
|Roll Call Votes:||There have been 2 roll call votes|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.2851 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (06/08/2017)
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 or the SITSA Act
This bill amends the Controlled Substances Act to establish a new, sixth schedule of controlled substances—schedule A. A drug or substance in schedule A has a chemical structure that is similar to, and an effect on the body that is similar to or greater than, a controlled substance in schedule I, II, III, IV, or V.
The bill adds 13 synthetic fentanyl-related substances to schedule A. It also authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently place a drug or substance in schedule A.
The bill establishes criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute a schedule A substance. However, it explicitly prohibits criminal and civil penalties solely for possession of a schedule A controlled substance.
The bill makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a schedule A substance that is not clearly labeled.
Finally, it establishes new, separate DEA registration requirements for manufacturers, distributors, and importers and exporters of schedule A substances.